Steve Aselage is a director of Acer Therapeutics Inc.
Person profile
Roles
Acer Therapeutics
Director
Biocryst Pharmaceuticals
Director
Address
Fremont, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Acer Therapeutics Inc.
20 Nov 23
4
BIOCRYST PHARMACEUTICALS INC
15 Jun 23
4
Acer Therapeutics Inc.
16 Mar 23
4
Acer Therapeutics Inc.
1 Dec 22
4
BIOCRYST PHARMACEUTICALS INC
9 Jun 22
4
BIOCRYST PHARMACEUTICALS INC
2 Jun 22
4
Travere Therapeutics, Inc.
12 May 22
4
BIOCRYST PHARMACEUTICALS INC
2 Mar 22
4
Acer Therapeutics Inc.
19 Jan 22
4
Acer Therapeutics Inc.
13 Dec 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Nov 23 | ACER Acer Therapeutics | Common Stock, $0.0001 par value per share | Sale back to company | Dispose D | No | No | 0 | 483,741 | 0.00 | 0 |
13 Jun 23 | BCRX Biocryst Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 16,745 | 0.00 | 63,339 |
13 Jun 23 | BCRX Biocryst Pharmaceuticals | Automatic Stock Option Grant Common Stock | Grant | Acquire A | No | No | 8.18 | 39,072 | 319.61 k | 39,072 |
14 Mar 23 | ACER Acer Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.67 | 20,000 | 33.40 k | 20,000 |
29 Nov 22 | ACER Acer Therapeutics | Common Stock | Buy | Acquire P | No | No | 1.22 | 409,836 | 500.00 k | 483,741 |